Psychiatric Genomics Consortium:

Pathways to Therapeutics

Building Bridges Between Industry, Psychiatry, and Psychology

April 29th – May 1st, 2020


organised by the Institute of Psychiatry, Psychology and Neuroscience,

King's College London


We hope you are well during this time.

Aware that under the current COVID-19 pandemic it is impossible to travel, and in order to better play our part in reducing the impact and spread of the novel coronavirus, we have decided to deliver the PGC Pathways to Therapeutics meeting online. Additionally, we have decided to extend the event by one day 29th April – 1st May, 2020 and we will modify the time schedule so that colleagues from the Americas will have the opportunity to attend the meeting.


  • Psychiatric Genomics Consortium - Updates on recents discovery and genetic methods
  • Drug targets and development - How to translate genetic findings
  • Talking Therapies - Online and app based treatment and genetics
  • Systems biology and chemoinformatics - Hypothesis generation from data-led approaches




Prof. Gerome Breen, Psychiatric Genomics Consortium (PGC) Network and Pathways Group & NIHR Maudsley BRC for Mental Health, King's College London

Dr. Topher Hübel (for any question:, PGC, King's College London